Status: Recruiting
Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
The purpose of this study is to determine whether pembrolizumab given after standard ablative Radiotherapy is a safe treatment that causes few or mild side effects in people with advanced Adrenocortical Carcinoma.
Participants needed: 12
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Memorial Sloan Kettering Cancer CenterUpdated: Apr 15, 2026Locations: 7
Eligibility criteria
Be willing and able to provide written informed consent for the trial. [+12]
Is currently participating in or has participated in a study of an investigation... [+13]